Kenny Roose

3.8k citations

37 papers · 2.3k indexed · 1 hit paper · h-index 25

Molecular Biology top 10%
Epidemiology top 5%
Immunology top 5%
Infectious Diseases top 2%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Xavier Saelens Lien Van Hoecke Bert Schepens Walter Fiers Michael Schotsaert Marina De Filette Emma R. Job Karim El Bakkouri
Topics: Influenza Virus Research Studies (20 papers)Monoclonal and Polyclonal Antibodies Research (15 papers)Immunotherapy and Immune Responses (9 papers)
Cited by: Immunology Infectious Diseases Epidemiology
Journals: Cell Journal of Biological Chemistry Nature Communications
Partner nations: Belgium Germany Netherlands

In The Last Decade

Kenny Roose

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies

2020 387 citations Daniel Wrapp, Dorien De Vlieger et al. Cell profile →

Peers

Countries citing papers authored by Kenny Roose

Since Specialization

Citations

This map shows the geographic impact of Kenny Roose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenny Roose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenny Roose more than expected).

Fields of papers citing papers by Kenny Roose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenny Roose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenny Roose. The network helps show where Kenny Roose may publish in the future.

Co-authorship network of co-authors of Kenny Roose

This figure shows the co-authorship network connecting the top 25 collaborators of Kenny Roose. A scholar is included among the top collaborators of Kenny Roose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenny Roose. Kenny Roose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses 2025 ·PubMed ·(unknown),Jan Félix,João Paulo Portela Catani,Kenny Roose,Wim Nerinckx,(unknown),Daria Fijałkowska,Nico Callewaert,Savvas N. Savvides,Xavier Saelens	0
2	In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression 2021 ·mBio ·Silvie Van den Hoecke,Marlies Ballegeer,Bram Vrancken,Lei Deng,Emma R. Job,Kenny Roose,Bert Schepens,Lien Van Hoecke,Philippe Lemey,Xavier Saelens	6
3	Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodiesbreakdown → 2020 ·Cell ·Daniel Wrapp,Dorien De Vlieger,Kizzmekia S. Corbett,Gretel M. Torres,Nianshuang Wang,Wander Van Breedam,Kenny Roose,Loes van Schie,Markus Hoffmann,Stefan Pöhlmann,Barney S. Graham,Nico Callewaert,Bert Schepens,Xavier Saelens,Jason S. McLellan	387
4	mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice 2020 ·Molecular Therapy — Nucleic Acids ·Lien Van Hoecke,Rein Verbeke,Dorien De Vlieger,Heleen Dewitte,Kenny Roose,(unknown),Olga Krysko,Claus Bachert,Bert Schepens,Ine Lentacker,Xavier Saelens	29
5	The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration 2020 ·Molecular Therapy — Nucleic Acids ·Lien Van Hoecke,Kenny Roose,Marlies Ballegeer,Zifu Zhong,Niek N. Sanders,Stefaan De Koker,Xavier Saelens,Sandra Van Lint	35
6	Mx1 in Hematopoietic Cells Protects against Thogoto Virus Infection 2019 ·Journal of Virology ·Jan Spitaels,Lien Van Hoecke,Kenny Roose,Georg Kochs,Xavier Saelens	24
7	How mRNA therapeutics are entering the monoclonal antibody field 2019 ·Journal of Translational Medicine ·Lien Van Hoecke,Kenny Roose	146
8	Removal of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization 2018 ·Viruses ·(unknown),(unknown),(unknown),Isabel Pintelon,Kenny Roose,Bert Schepens,Xavier Saelens,Dalan Bailey,Wim Martinet,Guy Caljon,Louis Maes,Paul Cos,Peter Delputte	18
9	Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes 2018 ·Nature Communications ·Lien Van Hoecke,Sandra Van Lint,Kenny Roose,Alexander Van Parys,Peter Vandenabeele,Johan Grooten,Jan Tavernier,Stefaan De Koker,Xavier Saelens	118
10	Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration 2017 ·Journal of Visualized Experiments ·Lien Van Hoecke,Emma R. Job,Xavier Saelens,Kenny Roose	50
11	Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12 2017 ·Scientific Reports ·Stefaan De Koker,Lien Van Hoecke,Alain De Beuckelaer,Kenny Roose,Kim Deswarte,Monique Willart,Pieter Bogaert,Thomas Naessens,Bruno G. De Geest,Xavier Saelens,Bart N. Lambrecht,Johan Grooten	30
12	Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection 2017 ·Antiviral Research ·(unknown),Kenny Roose,Anouk Smet,Bert Schepens,Peter Kufer,Tobias Raum,Patrick A. Baeuerle,(unknown),Xavier Saelens,Walter Fiers	15
13	A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody 2015 ·PLoS ONE ·(unknown),Judith Verhelst,Silvie Van den Hoecke,Anouk Smet,Michael Schotsaert,Emma R. Job,Kenny Roose,Bert Schepens,Walter Fiers,Xavier Saelens	20
14	Influenza vaccines to control influenza-associated bacterial infection: where do we stand? 2014 ·Expert Review of Vaccines ·(unknown),Kenny Roose,Lorena Itatí Ibañez,Xavier Saelens	22
15	Sequence-dependent Internalization of Aggregating Peptides 2014 ·Journal of Biological Chemistry ·José R. Couceiro,Rodrigo Gallardo,Frederik De Smet,Greet De Baets,Pieter Baatsen,Wim Annaert,Kenny Roose,Xavier Saelens,Joost Schymkowitz,Frédéric Rousseau	19
16	Hepatitis B core–based virus–like particles to present heterologous epitopes 2013 ·Expert Review of Vaccines ·Kenny Roose,(unknown),Bert Schepens,Xavier Saelens	57
17	M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A 2013 ·PLoS ONE ·Lorena Itatí Ibañez,Kenny Roose,Marina De Filette,Michael Schotsaert,(unknown),S. Roels,Charlotte Pollard,Bert Schepens,Johan Grooten,Walter Fiers,Xavier Saelens	41
18	Correction: A20 (Tnfaip3) Deficiency in Myeloid Cells Protects against Influenza A Virus Infection 2012 ·PLoS Pathogens ·Jonathan Maelfait,Kenny Roose,Pieter Bogaert,Mozes Sze,Xavier Saelens,Manolis Pasparakis,Isabelle Carpentier,Geert Loo,Rudi Beyaert	9
19	M2e-based universal influenza A vaccine 2009 ·Vaccine ·Walter Fiers,Marina De Filette,Karim El Bakkouri,Bert Schepens,Kenny Roose,Michael Schotsaert,Ashley J. Birkett,Xavier Saelens	289
20	An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2 2008 ·Journal of Biological Chemistry ·Marina De Filette,(unknown),Kenny Roose,Tom Deroo,(unknown),Mostafa Bentahir,Joël Vandekerckhove,Walter Fiers,Xavier Saelens	111

About Kenny Roose

Kenny Roose is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 37 papers that have together received 2.3k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (20 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Immunology (841 citations), Infectious Diseases (711 citations) and Epidemiology (903 citations). Kenny Roose has collaborated with scholars based in Belgium, Germany and Netherlands. Frequent co-authors include Xavier Saelens, Lien Van Hoecke, Bert Schepens, Walter Fiers, Michael Schotsaert, Marina De Filette, Emma R. Job, Karim El Bakkouri, Ashley J. Birkett and Stefaan De Koker. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact